- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
SkinBioTherapeutics PLC (SBTX)
SkinBioTherapeutics PLC stock price live, this page displays LON SBTX stock exchange data. View the SBTX premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the SkinBioTherapeutics PLC real time stock price chart below.
What Is the SkinBioTherapeutics PLC Stock Price Today?
The SkinBioTherapeutics PLC stock price today is 16.75.
What Is the Stock Symbol for SkinBioTherapeutics PLC?
The stock symbol for SkinBioTherapeutics PLC is "SBTX."
What Stock Exchange Does SkinBioTherapeutics PLC Trade On?
SkinBioTherapeutics PLC is listed and trades on the London stock exchange.
Is SkinBioTherapeutics PLC a Good Stock to Buy?
Determining whether SkinBioTherapeutics PLC—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the SBTX quote. (ISIN: GB00BF33H870)
What Is the SkinBioTherapeutics PLC Stock Price Today?
The SkinBioTherapeutics PLC stock price today is 16.75.
What Is the Stock Symbol for SkinBioTherapeutics PLC?
The stock symbol for SkinBioTherapeutics PLC is "SBTX."
What Stock Exchange Does SkinBioTherapeutics PLC Trade On?
SkinBioTherapeutics PLC is listed and trades on the London stock exchange.
Is SkinBioTherapeutics PLC a Good Stock to Buy?
Determining whether SkinBioTherapeutics PLC—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the SBTX quote. (ISIN: GB00BF33H870)
London
Currency in GBP
16.75
0.00(0.00%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
16.75
16.95
52 wk Range
0.17
27.50
SBTX Scorecard
Full Analysis
Analysts anticipate sales growth in the current year
SBTX is not included in our AI-picked strategies. See which stocks are.
Review Strategies
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
16.7516.95
52 wk Range
0.1727.50
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
SBTX Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Strong Buy
Price Target
29.00
Upside
+73.13%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts do not anticipate the company will be profitable this year
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Sell
Moving Averages
Sell
SkinBioTherapeutics Company Profile
SkinBioTherapeutics plc, a life science company, engages in research and development, and commercialization of technology that harnesses the microbiome for human health in the United Kingdom, the United States, Europe, and internationally. It develops SkinBiotix technology that harnesses microbiome to promote wound healing and reduce the risk of infection; AxisBiotix-Ps, which alleviate the symptoms associate with psoriasis; and MediBiotix, CleanBiotix, and PharmaBiotix which are in early stages of development. The company has an agreement with Croda Plc for the development of SkinBiotix as an active ingredient for the skicare/cosmetic industry. It serves cosmetic skincare, food supplements, medical skin care, infection control, and pharmaceutical skincare markets. The company was formerly known as Skinbiotix Ltd and changed its name to SkinBioTherapeutics plc in December 2016. SkinBioTherapeutics plc was incorporated in 2015 and is based in Newcastle upon Tyne, the United Kingdom.
Compare SBTX to Peers and Sector
Metrics to compare | SBTX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipSBTXPeersSector | |
|---|---|---|---|---|
P/E Ratio | −16.8x | −4.0x | −0.5x | |
PEG Ratio | −0.66 | −0.04 | 0.00 | |
Price/Book | 9.7x | 2.0x | 2.6x | |
Price / LTM Sales | 16.2x | 11.4x | 3.1x | |
Upside (Analyst Target) | 73.1% | 155.6% | 47.8% | |
Fair Value Upside | Unlock | 15.4% | 6.9% | Unlock |
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 29.00
(+73.13% Upside)
Earnings
Latest Release
Mar 26, 2025
EPS / Forecast
-- / --
Revenue / Forecast
1.58M / --
FAQ
What Is the SkinBioTherapeutics (SBTX) Stock Price Today?
The SkinBioTherapeutics stock price today is 16.75.
What Stock Exchange Does SkinBioTherapeutics Trade On?
SkinBioTherapeutics is listed and trades on the London Stock Exchange stock exchange.
What Is the Stock Symbol for SkinBioTherapeutics?
The stock symbol for SkinBioTherapeutics is "SBTX."
What Is the SkinBioTherapeutics Market Cap?
As of today, SkinBioTherapeutics market cap is 43.84M.
What Is SkinBioTherapeutics's Earnings Per Share (TTM)?
The SkinBioTherapeutics EPS (TTM) is -0.01.
When Is the Next SkinBioTherapeutics Earnings Date?
SkinBioTherapeutics will release its next earnings report on 03 Dec 2025.
From a Technical Analysis Perspective, Is SBTX a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has SkinBioTherapeutics Stock Split?
SkinBioTherapeutics has split 1 times.
How Many Employees Does SkinBioTherapeutics Have?
SkinBioTherapeutics has 15 employees.
What is the current trading status of SkinBioTherapeutics (SBTX)?
As of 09 Jul 2025, SkinBioTherapeutics (SBTX) is trading at a price of 16.75, with a previous close of 16.75. The stock has fluctuated within a day range of 16.75 to 16.95, while its 52-week range spans from 0.17 to 27.50.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.